Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
6,105 total articles
Swatch Group is an underappreciated play on luxury resilience, brand diversification and margin recovery. We upgrade to Buy and lay out an actionable trade with a $240 entry, $300 target and $200 stop, supported by four concrete catalysts and a balanced risk plan.
TG Therapeutics (TGTX) is a 'Strong Buy' at current levels. BRIUMVI's rapid commercial traction, upgraded 2025 guidance and improving technicals justify a long trade into a 180-day horizon. The plan balances upside to the drug's share gains against execution and regulatory risks with a disciplined stop.
XLP has become the go-to defensive play as investors rotate out of expensive growth. Fundamentals - steady earnings, a 2.45% yield and market-cap concentration in resilient names - combined with technical support argue for a measured long. Entry $89.84, stop $86.00, target $95.00. Hold horizon: long term (180 trading days).
Baldwin Insurance (BWIN) is a beaten-down, diversified insurance broker that has been punished more for narrative risk around AI and headline selling than for its underlying fundamentals. The stock is trading at $22.94 after a big intraday pop on expanding volume. We view current headlines as an overreaction and recommend a mid-term swing long: ent…
Opera (OPRA) is executing on higher-value user monetization and layering AI features into its browser stack. With revenue acceleration in recent quarters, a 5% dividend yield, PE ~17 and a market cap of about $1.43B, the stock offers yield plus upside if execution continues. This is a tactical long with a clear entry, stop and $21.06 target based o…
BitFuFu (BFFU) completed a full operational reset and is now trading at levels that underweight the value of a streamlined core business and potential product relaunch. This trade idea targets a mid-term rebound while keeping a tight stop in case execution stalls.
Root has transformed from a growth story into a profitable, telematics-driven insurer. The stock is down sharply from its 52-week highs and trading near the year low; we present a mid-term swing trade that buys the weakness with a clear stop and a constructive target tied to improving fundamentals and multiple expansion.
Microsoft's fundamentals remain robust - double-digit returns on capital, $77B in free cash flow and manageable leverage - but recent selling has driven sentiment into a more negative zone. That combination creates an asymmetric risk-reward for a mid-term (45 trading days) long. This trade targets a rebound toward fairer multiples while keeping a h…
Iridium has moved off its 2025 low and now shows improving technical momentum, healthy free cash flow and exposure to a growing satellite communications market. We upgrade to a mid-term long with a $22.99 entry, $20.00 stop and $30.00 target — a risk-reward profile we find attractive given current fundamentals and near-term catalysts.
Strategy Inc. (MSTR) trades near $130 after a headline-loss-driven sell-off. The company's operating business shows healthy ROE/ROA and low leverage while the market cap sits ~ $44B. My contrarian view: headline volatility has created an asymmetric risk/reward for a disciplined long. Entry $125, stop $95, target $320 over a 180 trading-day horizon.
Global Industrial (GIC) is trading below recent highs despite resilient margins, positive free cash flow and a healthy balance sheet. At roughly $33, the stock offers a dividend yield of ~3.1%, EV/S near 0.9 and EV/EBITDA ~12.1. This trade targets upside as Indoff integration and e-commerce tailwinds reaccelerate volumes; risk controls focus on inv…
Sprouts Farmers Market (SFM) has been marked down sharply from its 52-week high, but fundamentals — including $467.7M in free cash flow, a 37% return on equity, and a debt-light balance sheet — argue for a long-term buy. This idea lays out an actionable long trade with entry, stop and target, plus the catalysts and risks that will determine whether…
Pandora's strategic shift toward platinum-focused assortments and higher average selling prices presents a tangible margin and brand-repositioning opportunity. This trade idea outlines a mid-term long with entry, stop and target, the fundamental case for why the market should pay up, key catalysts to watch, and the risks that could derail the thesi…
NTB combines a geographically concentrated wealth-and-retail banking franchise, a 3.56% yield, and a sub-10x P/E. We like a long trade: entry $51.00, stop $47.00, target $64.00 over 180 trading days, playing for continued earnings upgrades, dividend stability, and multiple expansion.
Ambev (ABEV) combines a chunky 6.1% yield, margin expansion and a meaningful buyback with constructive technicals. I outline a mid-term trade (45 trading days) to capture further upside while protecting capital with a tight stop. The plan leans on continued margin recovery in Brazil and buyback support, but includes clear triggers that would invali…
Service Corporation International (SCI) trades around $83.52 with a $11.6B market cap and an enterprise value of $16.5B. Strong free cash flow ($484M), a 15-year dividend increase streak and recent buyback capacity suggest capital returns can support a re-rating if funeral and cemetery metrics stabilize. We propose a mid-term swing long at $83.50 w…
Cohen & Company (COHN) trades at a single-digit P/E and sub-1x book value with meaningful free cash flow and an active dividend policy. Technical momentum is weak and leverage appears elevated, which helps explain investor caution. This trade idea targets a bounce back toward the mid-$20s while respecting downside risk from capital structure and cy…
Urban Outfitters (URBN) pairs durable brand momentum and subscription growth with a conservative valuation. With a market cap near $6.0B, P/E around 12-13, and free cash flow of ~$403M, the stock offers asymmetric upside into $82 while providing defined downside protection via a $58 stop.
Blue Owl (OWL) has been smashed by redemption headlines and forced liquidations, but the firm's underlying cash generation and a recent CEO commitment to return capital create a clear, actionable trade. Entry $10.90, stop $9.80, target $15.00 over a mid-term (45 trading days) horizon.
FormFactor looks poised for an earnings inflection driven by HBM4 design wins and a stronger ASP mix in probe cards and test sockets. This trade idea lays out an actionable long with entry at $38.00, a stop at $30.00 and staged targets at $55.00 and $72.00 across a 180-trading-day horizon.
Trinity Capital (TRIN) offers a 13%+ headline yield, a switch to monthly payouts, and valuation metrics (P/B ~1.13, P/E ~7.8) that look attractive versus the risk. This trade idea targets a mid-term rebound into the $17 area with a strict stop below $13.50 — a plan that balances income capture and capital preservation while acknowledging credit and…
Super Micro (SMCI) has ridden AI infrastructure demand to eye-popping revenue growth, yet investors are fretting margin erosion. With a market cap near $19.1B and a P/E in the low-20s, the stock looks priced for growth but not perfection. This trade targets a position-sized rebound over the next 46-180 trading days while protecting capital if margi…
Alphabet is down from its February highs after a market-wide tech pullback. The pullback has pushed the stock toward key short-term support, with fundamentals — $73.3B free cash flow, $3.7T market cap, and a 31.8% ROE — arguing this is a lower-risk re-entry for a mid-term swing. We lay out an actionable trade with precise entry, stop and target and…
Nvidia's fundamentals remain exceptional - 65% revenue growth and dominant margins - but the stock is under pressure because shareholders aren't getting meaningful direct rewards (dividends or buybacks). That combination increases sensitivity to sentiment and makes NVDA a candidate for a tactical short into key support. Trade plan included for a mi…
Dupixent's continued label expansion and durable demand combine with Regeneron's strong free cash flow and light leverage to make REGN an actionable long. The company trades at a reasonable P/E for a near-term growth story, and a targeted entry around $770 with a $720 stop and $840 target gives a constructive risk/reward over a 180 trading-day hori…
